From: Meta-analysis of prophylactic corticosteroid use in post-ERCP pancreatitis
Method | Patients | Pooled OR (95% CI) | p |
---|---|---|---|
 | PEP | ||
A | 2632 | 1.13 (0.89, 1.44) | 0.32 |
B | 2328 | 1.20 (0.93, 1.55) | 0.17 |
C | 2247 | 1.10 (0.85, 1.43) | 0.47 |
D | 2448 | 1.13 (0.88, 1.46) | 0.34 |
 | Severe PEP | ||
A | 2257 | 1.61 (0.74, 3.52) | 0.23 |
B | 2073 | 1.80 (0.68, 4.72) | 0.23 |
C | 1872 | 1.35 (0.47, 3.91) | 0.58 |
D | 2073 | 1.80 (0.68, 4.72) | 0.23 |
 | Post-ERCP hyperamylasemia | ||
A | 412 | 0.92 (0.57, 1.48) | 0.73 |
B | 228 | 0.87 (0.52, 1.46) | 0.60 |
C | 228 | 0.87 (0.52, 1.46) | 0.60 |
D | 228 | 0.87 (0.52, 1.46) | 0.60 |